These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 38707135)
1. A Patient With Charcot-Marie-Tooth Disease Type 4C (CMT4C) Presenting With Muscle Fasciculations and Motor Neuropathy. Peddareddygari LR; Grewal RP Cureus; 2024 Apr; 16(4):e57550. PubMed ID: 38707135 [TBL] [Abstract][Full Text] [Related]
2. Gene replacement therapy in a model of Charcot-Marie-Tooth 4C neuropathy. Schiza N; Georgiou E; Kagiava A; Médard JJ; Richter J; Tryfonos C; Sargiannidou I; Heslegrave AJ; Rossor AM; Zetterberg H; Reilly MM; Christodoulou C; Chrast R; Kleopa KA Brain; 2019 May; 142(5):1227-1241. PubMed ID: 30907403 [TBL] [Abstract][Full Text] [Related]
3. Clinical and Genetic Analysis of an Asian Indian Family with Charcot-Marie-Tooth Disease Type 4C. Grewal RP; Oberoi K; Peddareddygari LR Case Rep Neurol; 2018; 10(1):38-44. PubMed ID: 29515423 [TBL] [Abstract][Full Text] [Related]
5. Genetic Landscape of Shchagina O; Murtazina A; Chausova P; Orlova M; Dadali E; Kurbatov S; Kutsev S; Polyakov A Front Genet; 2024; 15():1381915. PubMed ID: 38903759 [TBL] [Abstract][Full Text] [Related]
6. Screening for SH3TC2 variants in Charcot-Marie-Tooth disease in a cohort of Chinese patients. Sun B; He ZQ; Li YR; Bai JM; Wang HR; Wang HF; Cui F; Yang F; Huang XS Acta Neurol Belg; 2022 Oct; 122(5):1169-1175. PubMed ID: 33587240 [TBL] [Abstract][Full Text] [Related]
8. Novel mutations in SH3TC2 in a young Japanese girl with Charcot-Marie-Tooth disease type 4C. Ichikawa K; Numasawa K; Takeshita S; Hashiguchi A; Takashima H Pediatr Int; 2016 Nov; 58(11):1252-1254. PubMed ID: 27882734 [TBL] [Abstract][Full Text] [Related]
9. Neuropathy due to bi-allelic SH3TC2 variants: genotype-phenotype correlation and natural history. Rehbein T; Wu TT; Treidler S; Pareyson D; Lewis R; Yum SW; McCray BA; Ramchandren S; Burns J; Li J; Finkel RS; Scherer SS; Zuchner S; Shy ME; Reilly MM; Herrmann DN Brain; 2023 Sep; 146(9):3826-3835. PubMed ID: 36947133 [TBL] [Abstract][Full Text] [Related]
10. Dropped head syndrome as a manifestation of Charcot-Marie-Tooth disease type 4C. de Oliveira CM; Fussiger H; Winckler PB; Saute JAM Neuromuscul Disord; 2019 Feb; 29(2):138-141. PubMed ID: 30658898 [TBL] [Abstract][Full Text] [Related]
11. Screening for SH3TC2 gene mutations in a series of demyelinating recessive Charcot-Marie-Tooth disease (CMT4). Piscosquito G; Saveri P; Magri S; Ciano C; Gandioli C; Morbin M; Bella DD; Moroni I; Taroni F; Pareyson D J Peripher Nerv Syst; 2016 Sep; 21(3):142-9. PubMed ID: 27231023 [TBL] [Abstract][Full Text] [Related]
12. Characteristics of Clinical and Electrophysiological Pattern in a Large Cohort of Chinese Patients With Charcot-Marie-Tooth 4C. Duan X; Ma Y; Fan D; Liu X Front Neurol; 2021; 12():598168. PubMed ID: 33643188 [TBL] [Abstract][Full Text] [Related]
13. Charcot-Marie-Tooth Disease Type 4C and Autosomal Dominant Heterozygous Ichthyosis Vulgaris, with Bilateral Hearing Loss: A Novel Association with Review of Literature. Chhajed M; Gunasekaran PK; Bhanudeep S; Saini L J Pediatr Genet; 2024 Jun; 13(2):110-115. PubMed ID: 38721572 [TBL] [Abstract][Full Text] [Related]
14. Charcot-Marie-Tooth disease type 4C in Japan: report of a case. Iguchi M; Hashiguchi A; Ito E; Toda K; Urano M; Shimizu Y; Takeuchi C; Saito K; Takashima H; Uchiyama S Muscle Nerve; 2013 Feb; 47(2):283-6. PubMed ID: 23281072 [TBL] [Abstract][Full Text] [Related]
15. Inherited demyelinating neuropathies with micromutations of peripheral myelin protein 22 gene. Taioli F; Cabrini I; Cavallaro T; Acler M; Fabrizi GM Brain; 2011 Feb; 134(Pt 2):608-17. PubMed ID: 21252112 [TBL] [Abstract][Full Text] [Related]
16. Neuromuscular Junction Changes in a Mouse Model of Charcot-Marie-Tooth Disease Type 4C. Cipriani S; Phan V; Médard JJ; Horvath R; Lochmüller H; Chrast R; Roos A; Spendiff S Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30562927 [TBL] [Abstract][Full Text] [Related]
17. AAV9-mediated SH3TC2 gene replacement therapy targeted to Schwann cells for the treatment of CMT4C. Georgiou E; Kagiava A; Sargiannidou I; Schiza N; Stavrou M; Richter J; Tryfonos C; Heslegrave A; Zetterberg H; Christodoulou C; Kleopa KA Mol Ther; 2023 Nov; 31(11):3290-3307. PubMed ID: 37641403 [TBL] [Abstract][Full Text] [Related]
18. Exclusive expression of the Rab11 effector SH3TC2 in Schwann cells links integrin-α6 and myelin maintenance to Charcot-Marie-Tooth disease type 4C. Vijay S; Chiu M; Dacks JB; Roberts RC Biochim Biophys Acta; 2016 Jul; 1862(7):1279-90. PubMed ID: 27068304 [TBL] [Abstract][Full Text] [Related]